loadpatents
name:-0.014299154281616
name:-0.012156963348389
name:-0.0026509761810303
Puri; Raj K. Patent Filings

Puri; Raj K.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Puri; Raj K..The latest application filed is for "interleukin-4 receptor-binding fusion proteins and uses thereof".

Company Profile
2.11.14
  • Puri; Raj K. - Potomac MD
  • Puri; Raj K. - Bethesda MD
  • Puri, Raj K - Potomac MD
  • Puri, Raj K. - North Potomac MD
  • Puri; Raj K. - North Potamac MD
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Interleukin-4 receptor-binding fusion proteins and uses thereof
Grant 11,352,402 - Merchant , et al. June 7, 2
2022-06-07
Interleukin-4 Receptor-binding Fusion Proteins And Uses Thereof
App 20220048965 - Merchant; Fahar ;   et al.
2022-02-17
Interleukin-4 receptor-binding fusion proteins and uses thereof
Grant 11,084,856 - Merchant , et al. August 10, 2
2021-08-10
Synergistic combination of IL-4, interferon gamma, and interferon alpha in treating ovarian cancer
Grant 10,849,960 - Puri , et al. December 1, 2
2020-12-01
Synergistic Combination Of Il4 Receptor Targeted Agents, Interferon Gamma, And Interferon Alpha For Use In Treating Ovarian Canc
App 20200282020 - Puri; Raj K. ;   et al.
2020-09-10
Targeted Cargo Protein Combination Therapy
App 20170202922 - PURI; Raj K.
2017-07-20
Targeted cargo protein combination therapy
Grant 9,629,899 - Puri April 25, 2
2017-04-25
Use of Cysteamine and Derivatives Thereof to Suppress Tumor Metastases
App 20160184242 - Puri; Raj K. ;   et al.
2016-06-30
Targeted Cargo Protein Combination Therapy
App 20160184398 - Puri; Raj K.
2016-06-30
Use of Cysteamine and Derivatives Thereof to Suppress Tumor Metastases
App 20140314841 - Puri; Raj K. ;   et al.
2014-10-23
Targeted Cargo Protein Combination Therapy
App 20130331334 - Puri; Raj K.
2013-12-12
Targeted Cargo Protein Combination Therapy
App 20100183545 - Puri; Raj K.
2010-07-22
Use Of Sterically Stabilized Cationic Liposomes To Efficiently Deliver Cpg Oligonucleotides In Vivo
App 20100104507 - Klinman; Dennis M. ;   et al.
2010-04-29
Chimeric molecule for the treatment of th2-like cytokine mediated disorders
Grant 7,541,040 - Puri , et al. June 2, 2
2009-06-02
Washing and chilling apparatus and method
App 20050214355 - Klinman, Dennis M. ;   et al.
2005-09-29
Chimeric molecule for the treatment of th2-like cytokine mediated disorders
App 20050142105 - Puri, Raj K ;   et al.
2005-06-30
Sensitization of cancer cells to immunoconjugate-induced cell death by transfection with il -13 receptor alpha chain
App 20040136959 - Puri, Raj K.
2004-07-15
IL-13 receptor specific chimeric proteins & uses thereof
App 20030129132 - Puri, Raj K. ;   et al.
2003-07-10
IL-13 receptor specific chimeric proteins and uses thereof
Grant 6,518,061 - Puri , et al. February 11, 2
2003-02-11
Compositions and methods for specifically targeting tumors
Grant 6,428,788 - Debinski , et al. August 6, 2
2002-08-06
Circularly permuted ligands and circularly permuted chimeric molecules
Grant 6,011,002 - Pastan , et al. January 4, 2
2000-01-04
IL-13 receptor specific chimeric proteins
Grant 5,919,456 - Puri , et al. July 6, 1
1999-07-06
Fusion proteins comprising circularly permuted ligands
Grant 5,635,599 - Pastan , et al. June 3, 1
1997-06-03
IL-13 receptor specific chimeric proteins and uses thereof
Grant 5,614,191 - Puri , et al. March 25, 1
1997-03-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed